| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |